|
GPHN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.871900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.928000E-01 |
| Normal-vs-Stage2 |
1.195590E-02 |
| Normal-vs-Stage3 |
5.671800E-01 |
| Normal-vs-Stage4 |
1.085960E-01 |
| Stage1-vs-Stage2 |
2.515700E-02 |
| Stage1-vs-Stage3 |
7.636000E-01 |
| Stage1-vs-Stage4 |
2.363200E-01 |
| Stage2-vs-Stage3 |
2.119700E-02 |
| Stage2-vs-Stage4 |
2.166200E-01 |
| Stage3-vs-Stage4 |
1.965360E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.360000E-01 |
| Normal-vs-AfricanAmerican |
3.957600E-01 |
| Normal-vs-Asian |
3.870800E-01 |
| Caucasian-vs-AfricanAmerican |
8.174600E-01 |
| Caucasian-vs-Asian |
8.265200E-01 |
| AfricanAmerican-vs-Asian |
9.525800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.138200E-01 |
| Normal-vs-Female |
2.999900E-02 |
| Male-vs-Female |
7.450000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.787600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.794560E-01 |
| Normal-vs-Age(61-80Yrs) |
5.502400E-03 |
| Normal-vs-Age(81-100Yrs) |
6.039700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.162200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.435800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.235700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.871500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.182300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.080990E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.666400E-01 |
| Classical-VS-Follicular |
8.309900E-02 |
| Classical-VS-Other |
6.244600E-01 |
| Classical-VS-Normal |
1.022180E-01 |
| Tall-VS-Follicular |
1.965010E-01 |
| Tall-VS-Other |
4.848000E-01 |
| Tall-VS-Normal |
2.396400E-01 |
| Follicular-VS-Other |
3.532200E-01 |
| Follicular-VS-Normal |
8.978900E-03 |
| Other-VS-Normal |
8.999600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.805700E-02 |
| Normal-vs-N1 |
9.520000E-01 |
| N0-vs-N1 |
1.427640E-01 |
|
|
